Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Author:

Paruch Kamil1,Dwyer Michael P.1,Alvarez Carmen1,Brown Courtney1,Chan Tin-Yau1,Doll Ronald J.1,Keertikar Kerry1,Knutson Chad1,McKittrick Brian1,Rivera Jocelyn1,Rossman Randall1,Tucker Greg1,Fischmann Thierry1,Hruza Alan1,Madison Vincent1,Nomeir Amin A.1,Wang Yaolin1,Kirschmeier Paul1,Lees Emma2,Parry David2,Sgambellone Nicole2,Seghezzi Wolfgang2,Schultz Lesley2,Shanahan Frances2,Wiswell Derek2,Xu Xiaoying1,Zhou Quiao1,James Ray A.3,Paradkar Vidyadhar M.3,Park Haengsoon3,Rokosz Laura R.3,Stauffer Tara M.3,Guzi Timothy J.1

Affiliation:

1. Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033

2. Merck Research Laboratories, 901 California Avenue, Palo Alto, California 94304

3. Ligand Pharmaceuticals (formerly Pharmacopeia), 3000 Eastpark Boulevard, Cranbury, New Jersey 08512

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3